Skip to main content

Want a detailed portfolio tracker?

Performance analysis of ArriVent BioPharma (AVBP)

Annual Return

Since Jan 26, 2024, AVBP has had an average annual return of +14.93%, underperforming the benchmark SPY, which returned +20.26% annual.

202620252024
+40.46%-24.47%+33.20%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+11.78%+2.13%+0.44%+34.76%-2.64%+14.77%-18.65%+40.46%
2025+7.13%-17.27%-21.69%+14.98%-0.05%+2.45%-10.38%-2.00%-3.50%+1.52%+22.48%-12.29%-24.47%
2024+7.75%-0.05%-17.08%-7.50%+17.49%-4.43%+18.06%+22.05%-12.08%+24.85%+2.11%-11.08%+33.20%

Drawdown analysis of ArriVent BioPharma (AVBP)

The maximum drawdown for the AVBP was -54.25%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current AVBP drawdown is -20.68%.

Since Jan 26, 2024 AVBP has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-54.25%Nov 7, 2024102Apr 8, 2025OngoingOngoingOngoing
-32.75%Mar 4, 202436Apr 24, 202473Aug 8, 2024109
-19.17%Sep 6, 202411Sep 23, 202414Oct 11, 202425
-15.71%Feb 16, 20245Feb 26, 20245Mar 4, 202410
-8.80%Oct 28, 20243Oct 31, 20244Nov 6, 20247
-6.20%Aug 27, 20244Sep 3, 20243Sep 6, 20247
-5.19%Feb 7, 20242Feb 9, 20245Feb 16, 20247
-4.90%Aug 8, 20241Aug 9, 20242Aug 13, 20243
-3.46%Oct 16, 20243Oct 21, 20241Oct 22, 20244
-2.18%Jan 30, 20244Feb 5, 20242Feb 7, 20246
-2.01%Aug 16, 20244Aug 22, 20242Aug 26, 20246
-1.06%Oct 11, 20241Oct 14, 20241Oct 15, 20242
-0.45%Jan 26, 20241Jan 29, 20241Jan 30, 20242
-0.38%Aug 14, 20241Aug 15, 20241Aug 16, 20242